An Open-Label Study of CTI-1601 in Subjects With Friedreich's Ataxia

NCT06447025 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
85
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Larimar Therapeutics, Inc.